Compound ID | 1247
VNRX-PBP
Class: Cell-wall synthesis inhibitor (beta-lactamase resistant PBP inhibitor)
| Spectrum of activity: | Gram-negative |
| Institute where first reported: | VenatoRx |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citation: | https://www.venatorx.com/pipeline/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.